New AI tool helps proactively screen, test and identify people at risk for COVID FAIRFAX, Va.--(BUSINESS WIRE)--Vibrent Health, a…
LOS ANGELES, Nov. 10, 2021 /PRNewswire/ -- Building on the success of the Optimal Wellbeing Program (OWP) that launched in…
Ovid is implementing its business development program which intends to secure a series of opportunities that complement and enhance its…
ACTON, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”) a late-stage, pre-revenue diagnostics/medical device company…
RAPIDe-1, Phase 2 on-demand study of PHVS416 for the treatment of HAE attacks, proceeding; topline data reaffirmed for 2022CHAPTER-1, Phase…
Live moderated video webcast discussion among members of management and Thought Leaders Firas M. Rahhal, MD and Robert L. Avery,…
WESTLAKE VILLAGE, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing…
Company to host conference call and webcast on Thursday, November 18, at 8:30 am ET LYON, France, November 10, 2021…
John Maraganore, Ph.D., Mark McClellan, M.D., Ph.D. and Andrew Lo, Ph.D. appointed as Executive Advisors to support SalioGen’s efforts to…
CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel…